The Effect of Metamin 3D on the Lipid and Glucose in Subjects With Metabolic Syndrome

• Status: Completed
• Trial end date: 2009-06-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the effect of Metamin 3D on improvement of glucose and lipid on Taiwanese subjects with metabolic syndrome.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Taichung Veterans General Hospital

Criteria

Inclusion Criteria:

• Age between 30 and 75 years

• Fasting plasma glucose >= 100 mg/dl

• Triglyceride >= 150 mg/dl

• one of the criteria following

1. HDL <40 mg/dl in man or <50 mg/dl in woman

2. Blood pressure >= 135/85 mmHg or anti-hypertension drug treatment

3. Waist >90cm in man or 80cm in woman

• Signed the inform consent

Exclusion Criteria:

• Fasting plasma glucose > 180mg/dl

• Treated by more than two types oral hypoglycemic agents in past 3 months

• Treated continuously by anti-lipid agents for 3 months in past 6 months

• Treated by thiazolidinedione or digitalis at present

• Serum creatine > 2.5mg/dl

• Liver function (GOT or GPT) more than 3-fold upper limit

• Severe systemic disease by investigator's judgement

• Pregnant or nursing women

• Enrolled in other clinical study in recent 1 month